As March unfolds, a wave of blue is sweeping across France and beyond, marking “Mars Bleu,” a national month dedicated to raising awareness about colorectal cancer. This year, the campaign gains momentum with initiatives like Asetis launching a mobile screening caravan in the south and west of France, aiming to reach underserved populations and promote early detection. Colorectal cancer remains a significant public health concern, but advancements in screening and treatment offer hope, particularly when the disease is identified in its early stages.
Colorectal cancer is the second leading cause of cancer-related deaths in France, according to the Institut National du Cancer. However, early detection dramatically improves outcomes, with a survival rate of over 90% when diagnosed at stage I. The key to this improved prognosis lies in regular screening, which can identify precancerous polyps before they develop into malignant tumors. Despite the proven benefits, participation rates in organized screening programs remain suboptimal, highlighting the need for increased awareness and accessibility.
Mobilizing for Prevention: Initiatives Across France
The “Mars Bleu” campaign isn’t limited to Asetis’s mobile caravan. Across France, various organizations and healthcare providers are joining forces to promote colorectal cancer prevention. The Centre Hospitalier Universitaire (CHU) of Besançon, for example, is embracing the campaign with a direct message: “Occupez-vous de vos fesses” (“Grab care of your bottoms”). This bold approach, launched on March 11, 2026, aims to break down taboos surrounding the disease and encourage individuals to prioritize screening. The CHU Besançon is hosting information stands and an artistic performance throughout the month to engage the public. maCommune.info details these efforts.
Beyond Besançon, communities are organizing local events to raise awareness. Near Angers, a course, walk, and hike are scheduled to promote screening. In the city of Besançon itself, the municipal government is actively supporting the campaign, working alongside the Ligue Contre le Cancer and the Centre Régional de Coordination des Dépistages des Cancers en Bourgogne-Franche-Comté. The city of Besançon’s website outlines a series of prevention stands scheduled throughout March, including locations at Clinique Saint-Vincent, Polyclinique de Franche-Comté, and various community centers.
Understanding Colorectal Cancer and Screening Options
Colorectal cancer develops in the colon or rectum, often starting as small, noncancerous polyps. Over time, these polyps can become cancerous. Symptoms can vary, and early-stage colorectal cancer often presents no noticeable symptoms, underscoring the importance of regular screening. When symptoms do appear, they may include changes in bowel habits, rectal bleeding, abdominal discomfort, and unexplained weight loss.
Several screening options are available, each with its own advantages and disadvantages. The most common method is the fecal immunochemical test (FIT), a simple, non-invasive test that detects hidden blood in the stool. This test can be performed at home and returned to a healthcare provider for analysis. If the FIT test is positive, a colonoscopy is recommended. However, a recent report in Sud Ouest highlights a concerning trend: after a positive FIT test, colonoscopies are often delayed, potentially impacting treatment outcomes. The report emphasizes the critical need for timely follow-up care.
Other screening options include sigmoidoscopy, which examines only the lower portion of the colon, and virtual colonoscopy, a non-invasive imaging procedure. The optimal screening strategy depends on individual risk factors, medical history, and preferences, and should be discussed with a healthcare professional.
The Role of Early Detection and the Asetis Caravan
The Asetis caravan, specifically targeting the south and west of France, represents a proactive approach to overcoming barriers to screening. These mobile units bring screening services directly to communities, making it more convenient for individuals to participate. The caravan’s efforts are particularly important in reaching populations with limited access to healthcare facilities or those who may be hesitant to seek medical attention.
The importance of early detection cannot be overstated. When colorectal cancer is diagnosed at stage I, the five-year survival rate is approximately 90%. However, this rate declines significantly as the cancer progresses. By identifying and removing precancerous polyps during screening, healthcare providers can prevent the development of colorectal cancer altogether.
Understanding Risk Factors
While anyone can develop colorectal cancer, certain factors can increase an individual’s risk. These include:
- Age: The risk increases significantly after age 50.
- Family History: Having a family history of colorectal cancer or polyps increases risk.
- Personal History: Individuals who have previously had colorectal cancer or polyps are at higher risk.
- Inflammatory Bowel Disease: Conditions like Crohn’s disease and ulcerative colitis can increase risk.
- Lifestyle Factors: A diet high in red and processed meats, obesity, physical inactivity, and smoking are associated with increased risk.
Emerging Research and Future Directions
Beyond screening and early detection, ongoing research is exploring latest avenues for preventing and treating colorectal cancer. Recent studies, such as one reported by Science et Vie, suggest a potential link between certain gut bacteria and the development of colon cancer, even in childhood. This research highlights the complex interplay between the gut microbiome and cancer risk, opening up possibilities for novel preventative strategies.
advancements in immunotherapy and targeted therapies are offering new hope for patients with advanced colorectal cancer. These treatments harness the power of the immune system to fight cancer cells and target specific genetic mutations that drive tumor growth.
The “Mars Bleu” campaign serves as a crucial reminder of the importance of proactive health management. By prioritizing screening, adopting a healthy lifestyle, and staying informed about the latest research, individuals can significantly reduce their risk of developing this preventable disease.
As the month progresses, continued efforts to raise awareness and improve access to screening will be vital. The next key date to watch is April 1st, when the Ligue Contre le Cancer will release updated statistics on colorectal cancer incidence and mortality in France.
What are your thoughts on the importance of colorectal cancer screening? Share your experiences and questions in the comments below. Don’t forget to share this article with your friends and family to support spread awareness!